Glenmark Pharmaceuticals Limited — Guaifenesin Exporter Profile
Indian Pharmaceutical Exporter · #8 for Guaifenesin · $594.8K export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #8 Indian exporter of Guaifenesin with $594.8K in export value and 30 verified shipments. Glenmark Pharmaceuticals Limited holds a 2.2% market share in Guaifenesin exports across 7 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Guaifenesin Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Guaifenesin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UZBEKISTAN | $151.8K | 13 | 29.5% |
| PHILIPPINES | $137.4K | 3 | 26.7% |
| KAZAKHSTAN | $116.7K | 5 | 22.6% |
| CAMBODIA | $94.1K | 4 | 18.3% |
| FIJI | $10.5K | 2 | 2.0% |
| POLAND | $4.2K | 2 | 0.8% |
| BARBADOS | $373 | 1 | 0.1% |
Glenmark Pharmaceuticals Limited exports Guaifenesin to 7 countries. The largest destination is UZBEKISTAN accounting for 29.5% of Glenmark Pharmaceuticals Limited's Guaifenesin shipments, followed by PHILIPPINES (26.7%) and KAZAKHSTAN (22.6%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Guaifenesin from Glenmark Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GLENMARK PHILIPPINES INC | PHILIPPINES | $137.4K | 3 |
| DKSH (CAMBODIA) LTD | CAMBODIA | $94.1K | 4 |
| LLC NOVOTEK | UZBEKISTAN | $82.1K | 4 |
| GRAND PHARM TRADE | UZBEKISTAN | $50.0K | 1 |
| AMANAT LTD. | KAZAKHSTAN | $42.6K | 1 |
| RAUZA ADE | KAZAKHSTAN | $26.4K | 1 |
| AMITY INTERNATIONAL | KAZAKHSTAN | $24.7K | 1 |
| LLC CURATIO PHARM | UZBEKISTAN | $19.7K | 1 |
| SCIENTIFIC PRODUCTION ASSOCIATION Z | KAZAKHSTAN | $17.4K | 1 |
| PHARMATEC PTE LIMITED | FIJI | $10.5K | 2 |
Glenmark Pharmaceuticals Limited supplies Guaifenesin to 15 buyers globally. The largest buyer is GLENMARK PHILIPPINES INC (PHILIPPINES), followed by DKSH (CAMBODIA) LTD (CAMBODIA) and LLC NOVOTEK (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Guaifenesin Export Value and How Much Does Glenmark Pharmaceuticals Limited Contribute?
India exported $19.9M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. Glenmark Pharmaceuticals Limited contributes $594.8K to this total, accounting for 2.2% of India's Guaifenesin exports. Glenmark Pharmaceuticals Limited ships Guaifenesin to 7 countries through 15 buyers.
What Is the Average Shipment Value for Glenmark Pharmaceuticals Limited's Guaifenesin Exports?
Glenmark Pharmaceuticals Limited's average Guaifenesin shipment value is $19.8K per consignment, based on 30 shipments totaling $594.8K. The largest destination is UZBEKISTAN (29.5% of Glenmark Pharmaceuticals Limited's Guaifenesin exports).
How Does Glenmark Pharmaceuticals Limited Compare to Other Indian Guaifenesin Exporters?
Glenmark Pharmaceuticals Limited ranks #8 among 151 Indian Guaifenesin exporters with a 2.2% market share. The top 3 exporters are GRANULES INDIA LIMITED ($9.1M), ELYSIUM PHARMACEUTICALS LTD ($3.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($899.7K). Glenmark Pharmaceuticals Limited processed 30 shipments to 7 destination countries.
What Guaifenesin Formulations Does Glenmark Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PECOF TABLETS 10X1X10' S (SALBUTAMOL SULPHATE, BROMHEXINE HCL,GUAIFENESIN TABLETS) (QTY: 9,662 CAR) | $50.0K | 1 |
| ASCORIL TABLETS 2X10'S (Salbutamol Sulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 30,000 CAR) | $50.0K | 1 |
| PECOF TABLETS 10X1X10' S (Salbutamol Sulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 4,776 CAR) | $44.5K | 1 |
| ASCORIL EXPECTORANT 100ML (Salbutamol Sulphate, Bromhexine Hcl, and GuaifenesinSyrup) (QTY: 6,480 BOT) | $44.1K | 2 |
| PECOF TABLETS 10X1X10 S Salbutamol Sulphate Bromhexine Hcl Guaifenesin Tablets QTY 4 758 CAR | $43.0K | 1 |
| Ascoril expectorant SF 100ml KZ (Salbutamol Sulphate,Bromhexine Hydrochloride and Guaifenesin Expectorant) (QTY: 10,000 | $42.6K | 1 |
| ASCORIL TABLETS 2X10'S (Salbutamol Sulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 8160 CAR) | $38.0K | 2 |
| ASCORIL TABLETS KH 10x1x10's (SalbutamolSulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 6,500 CAR) | $33.7K | 1 |
| Ascoril expectorant SF 200ml KZ (Salbutamol Sulphate,Bromhexine Hydrochloride and Guaifenesin Expectorant)(QTY: 4,800 BO | $26.4K | 1 |
| Ascoril expectorant SF 200ml KZ (Salbutamol Sulphate,Bromhexine Hydrochloride and Guaifenesin Expectorant)(QTY: 4280 BOT | $24.7K | 1 |
Glenmark Pharmaceuticals Limited exports 25 distinct Guaifenesin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PECOF TABLETS 10X1X10' S (SALBUTAMOL SULPHATE, BROMHEXINE HC with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Glenmark Pharmaceuticals Limited Compare to Nearest Guaifenesin Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AGIO PHARMACEUTICALS LIMITED | $781.2K | 34 | 3 | $23.0K |
| 7 | EMCURE PHARMACEUTICALS LIMITED | $645.9K | 46 | 11 | $14.0K |
| 8 | GLENMARK PHARMACEUTICALS LIMITED ★ | $594.8K | 30 | 7 | $19.8K |
| 9 | MARKSANS PHARMA LIMITED | $576.5K | 28 | 3 | $20.6K |
| 10 | DR.REDDY'S LABORATORIES LTD | $572.2K | 33 | 1 | $17.3K |
Glenmark Pharmaceuticals Limited ranks #8 among 151 Indian Guaifenesin exporters. Average shipment value of $19.8K compared to the market average of $131.8K. The closest competitors by value are AGIO PHARMACEUTICALS LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Guaifenesin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 118 | 11.2% |
| NHAVA SHEVA SEA (INNSA1) | 94 | 9.0% |
| JNPT | 74 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 70 | 6.7% |
| HYDERABAD AIR | 53 | 5.0% |
| HYDERABAD ICD (INSNF6) | 50 | 4.8% |
| MUNDRA SEA (INMUN1) | 50 | 4.8% |
| MUNDRA SEA | 47 | 4.5% |
What Other Respiratory & OTC Products Does Glenmark Pharmaceuticals Limited Export?
Glenmark Pharmaceuticals Limited also exports these respiratory & otc products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Glenmark Pharmaceuticals Limited's Guaifenesin Exports
Glenmark's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies like Glenmark to expand their footprint in the US market. The shifting trade dynamics have prompted US importers to seek alternative suppliers, presenting growth opportunities for Indian exporters.
The recent India-European Union Free Trade Agreement (FTA) is poised to benefit Glenmark by eliminating tariffs on pharmaceutical exports to the EU. This development enhances the company's competitiveness in the European market, potentially boosting export volumes and revenue streams. (en.wikipedia.org)
Glenmark Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Glenmark's export success. The company has consistently adhered to guidelines set by the US FDA, WHO, and EU GMP, ensuring the quality and safety of its products. Notably, Glenmark's manufacturing facilities have undergone rigorous inspections, reflecting its commitment to maintaining high-quality standards.
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous adaptation. Glenmark's proactive approach to compliance positions it well to navigate these changes, thereby sustaining its market access and reputation.
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited exports 28 products worth $205.5M. Beyond Guaifenesin, top products include Rosuvastatin, Omeprazole, Gabapentin, Ondansetron, Naproxen. View the complete Glenmark Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Glenmark Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching Glenmark Pharmaceuticals Limited exporting Guaifenesin, covering 25 formulations to 7 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Guaifenesin Export Data from Glenmark Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Glenmark Pharmaceuticals Limited's Guaifenesin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Glenmark Pharmaceuticals Limited
Full Company Profile →
28 products · $205.5M total trade · 14 categories
Guaifenesin Stats
Company Overview
Top Products by Glenmark Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Glenmark Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current shipment-level data, contact TransData Nexus.